SCHEMBL87256

SCHEMBL87256

C=C(C)CSC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL459298 0.74 — —
SCHEMBL386613 0.74 HSD17B10 (0.41) —
SCHEMBL10015725 0.74 — —
SCHEMBL17232428 0.71 — —
SCHEMBL1018195 0.71 — —
SCHEMBL294410 0.69 — —
SCHEMBL87260 0.69 — —
SCHEMBL14414574 0.69 — —
SCHEMBL87085 0.69 — —
SCHEMBL20464013 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192908-B2 Octamolybdate compounds exhibiting bright emission NANOCO 2D MATERIALS LIMITED (GB) 2021-12-07 — — US disclosed
EP-3837267-A1 POLYOXOMETALATE COMPOUNDS EXHIBITING BRIGHT EMISSION AND METHODS OF PRODUCING THE SAME Nanoco 2D Materials Limited (GB) 2021-06-23 — — EP disclosed
CN-112533934-A Polyoxometallate compounds exhibiting bright emission and methods of making the same 纳米2D材料有限公司 2021-03-19 — — CN disclosed
US-10701931-B2 Mosquito activating formulations COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2020-07-07 — — US disclosed
WO-2020035670-A1 POLYOXOMETALATE COMPOUNDS EXHIBITING BRIGHT EMISSION AND METHODS OF PRODUCING THE SAME NANOCO 2D MATERIALS LIMITED (GB) 2020-02-20 — — WO disclosed
US-20200055884-A1 Octamolybdate Compounds Exhibiting Bright Emission NANOCO TECHNOLOGIES LIMITED (GB) 2020-02-20 — — US disclosed
US-20190208777-A1 MOSQUITO ACTIVATING FORMULATIONS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2019-07-11 — — US disclosed
CN-108471744-A Mosquito-activating agent 联邦科学技术研究组织 2018-08-31 — — CN disclosed
EP-3361867-A1 MOSQUITO ACTIVATING FORMULATIONS Commonwealth Scientific and Industrial Research Organisation (AU) 2018-08-22 — — EP disclosed
WO-2017106914-A1 METHOD OF SCREENING COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2017-06-29 — — WO disclosed
US-7270883-B2 Film-forming composition, anti-reflection film, polarizing plate, image display apparatus, anti-pollution coating composition and anti-pollution article FUJIFILM CORPORATION (JP) 2007-09-18 — — US disclosed
US-7264329-B2 Inkjet recording head and inkjet recording device FUJIFILM CORPORATION (JP) 2007-09-04 — — US disclosed
WO-2007063702-A2 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-07 — — WO disclosed
EP-1304325-A1 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-04-23 — — EP disclosed
US-5594132-A ANTIBIOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-01-14 — — US disclosed
US-5026695-A Gram negative-gram positive microbiocides, oral adminis tration FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-06-25 — — US disclosed
US-4904652-A 7-acylamino-3-substituted cephalosporanic acid derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-02-27 — — US disclosed
EP-0029557-B1 7-ACYLAMINO-3-SUBSTITUTED CEPHALOSPORANIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-03-13 — — EP disclosed
US-4462999-A CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-07-31 — — US disclosed
US-4409215-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-10-11 — — US disclosed
Send feedback